Why the study?
Does DDD pacing with rate drop response function prevent syncope recurrence compared to DDI pacing with rate hysteresis in patients with cardioinhibitory vasovagal syncope?
Does DDD pacing with rate drop response function prevent syncope recurrence compared to DDI pacing with rate hysteresis in patients with cardioinhibitory vasovagal syncope?
DDD pacing with rate drop response function significantly reduces the recurrence of syncope compared to DDI pacing with rate hysteresis in patients with cardioinhibitory vasovagal syncope.
Answers are grounded in this paper and cite their sources.
Supports DDD with rate drop response over DDI in cardioinhibitory vasovagal syncope; extends RCT evidence for pacing mode selection.
BACKGROUND: The effectiveness of cardiac pacing in preventing vasovagal syncope remains controversial. However, DDI pacing with rate hysteresis has been reported to prevent the recurrence of cardioinhibitory vasovagal syncope in up to 35% of affected subjects and to reduce the overall incidence of syncopal episodes in the others. Recently, DDD pacing with a new promising rate drop response function (Medtronic Thera-I model 7960) has become available in clinical practice. AIM OF THE STUDY: The aim of the present open trial was to test the effectiveness of this new pacing modality in patients with cardioinhibitory vasovagal syncope. STUDY POPULATION AND METHODS: The study population included 20 patients (12 males and 8 females; mean age 61.1 +/- 14 yrs) with recurrent syncope (mean number of prior episode = 6.8, range 5-11) and cardioinhibitory responses during two head-up tilt tests: the first diagnostic and the second during drug therapy with either beta-blockade or etilephrine. The study patients were randomized to receive either DDI pacing with rate hysteresis (8 patients) or DDD pacing with rate drop response function (11 patients). The head-up tilt test performed 1 month after pacemaker implantation was positive in 3 of 12 patients (25%) with DDD pacing with rate drop response function and in 5 of 8 patients (62.5%) with DDI pacing with rate hysteresis. The mean duration of follow-up was 17.7 +/- 7.4 months. During follow-up no patients with a DDD pacemaker with rate drop response function had syncope, while 3 of 8 patients with a DDI pacemaker with rate hysteresis had recurrence of syncope (P < 0.05). CONCLUSIONS: These data suggest that DDD pacing with rate drop response function is effective in cardioinhibitory vasovagal syncope and may be preferable to DDI pacing with rate hysteresis.
No takes yet. Share an insight, caveat, or question.
Ammirati et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: